Corvus Aims To Master Adenosine Mechanisms For PD-1/L1 Failures

 
• By Emily Hayes
  
Emerging Company Profile Regular column feature image Version 2
Corvus Pharmaceuticals CEO Richard Miller

More from Start-Ups & SMEs

More from Business